Get started
Author

Tongyu Tong

ORCID: 0000-0002-5421-0666
Observed ORCID: 0000-0002-5421-0666
OpenAlex ID: A5086596288
SRC kinase-mediated signaling pathways and targeted therapies in breast cancer
2022 · Juan Luo, Hailin Zou, et al. · Breast Cancer Research · 114
PDF
Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis
2020 · Yupeng Guan, Haiyun Xiong, et al. · Prostate Cancer and Prostatic Diseases · 82
New insights into the ambivalent role of YAP/TAZ in human cancers
2023 · Juan Luo, Liang Deng, et al. · Journal of Experimental & Clinical Cancer Research · 80
PDF
The oncogenic roles and clinical implications of YAP/TAZ in breast cancer
2023 · Juan Luo, Hailin Zou, et al. · British Journal of Cancer · 66
PDF
A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
2020 · Tongyu Tong, Yupeng Guan, et al. · Frontiers in Oncology · 46
PDF
ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatment
2024 · Huikun Chen, Chengyuan Xing, et al. · Journal of Controlled Release · 44
Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer
2023 · Hailin Zou, Juan Luo, et al. · Cellular and Molecular Life Sciences · 35
PDF
Acidity-Actuated Polymer/Calcium Phosphate Hybrid Nanomotor (PCaPmotor) for Penetrating Drug Delivery and Synergistic Anticancer Immunotherapy
2024 · Bin Xu, Hanqi Lei, et al. · Nano Letters · 32
Cyclodextrin-based supramolecular nanoparticles break the redox balance in chemodynamic therapy-enhanced chemotherapy
2022 · Chengyuan Xing, Huikun Chen, et al. · Journal of Colloid and Interface Science · 17
Smart dual responsive nanocarriers with reactive oxygen species amplification assisted synergistic chemotherapy against prostate cancer
2022 · Yupeng Guan, Chengyuan Xing, et al. · Journal of Colloid and Interface Science · 16
Dual pH- and Glutathione-Responsive CO2-Generating Nanodrug Delivery System for Contrast-Enhanced Ultrasonography and Therapy of Prostate Cancer
2021 · Lujing Li, Tongyu Tong, et al. · ACS Applied Materials & Interfaces · 16
Smart nanocarriers as therapeutic platforms for bladder cancer
2021 · Tongyu Tong, Yupeng Guan, et al. · Nano Research · 15
Revealing Prognostic Value of Skeletal-Related Parameters in Metastatic Castration-Resistant Prostate Cancer on Overall Survival: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
2020 · Tongyu Tong, Hanqi Lei, et al. · Frontiers in Oncology · 8
PDF
HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer
2025 · Tongyu Tong, Hanqi Lei, et al. · Oncogene · 7
Hippo signaling modulation and its biological implications in urological malignancies
2024 · Tongyu Tong, Mengjun Huang, et al. · Molecular Aspects of Medicine · 7
Effective Sonosensitizer Delivery by Redox Sensitive Nanoparticles for Prostate Cancer Sonodynamic Therapy via Amplifying Oxidative Stress and Peroxidation
2022 · Tongyu Tong, Hanqi Lei, et al. · Advanced Healthcare Materials · 7
Targeting YAP1-CD70 axis potentiates the efficacy of anti-PD-1 therapy in prostate cancer
2026 · Tongyu Tong, Yupeng Guan, et al. · Biomarker Research · 3
PDF
PARP1-mediated PARylation of TEAD4 stabilizes the YAP1-TEAD4 complex and promotes growth and immune evasion in breast cancer cells
2025 · Yibo Guo, Gaoqing Song, et al. · Science Signaling · 3
CDK12 Inactivation Attenuates Prostate Cancer Progression by Inhibiting BNIP3 ‐Mediated Mitophagy
2025 · Mengjun Huang, Hanqi Lei, et al. · Cell Proliferation · 3
TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapy
2025 · Qiliang Teng, Niu Wang, et al. · Cancer Immunology Immunotherapy · 2
PDF
CDK12-Mediated Phosphorylation of FOXA1 Promotes Prostate Cancer Progression via the MDM2–p53 Axis
2025 · Binyuan Yan, Mengjun Huang, et al. · Research · 2
Causal relationships between plasma metabolites and prostate cancer: A Mendelian randomization study exploring immune and inflammatory mediators
2025 · Mengjun Huang, Dong Ning, et al. · Current Urology · 1
A cross-sectional study examining the relationship between the advanced lung cancer inflammation index and prostate cancer
2025 · Mengjun Huang, Qiliang Teng, et al. · Journal of Health Population and Nutrition · 1
PDF
Works count: 23
Citation count: 607
H-index: 12
I10-index: 12
Year
Topic
Type